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Although  the  thymus-derived  (T)  cells  1 and  their  progeny  (effector  cells) 
that  are involved in  allograft immunity and in humoral immunity have been 
extensively studied,  very little is known  about  the  differentiation of  T  cells 
from their progenitors. It is assumed that mouse bone marrow contains pluripo- 
tent stem cells, since transplantation of marrow into heavily irradiated recipi- 
ents results in  repopulation of the myeloid and lymphoid systems  (1-5).  The 
repopulation of  at  least a  portion  of  the  lymphoid system could  conceivably 
come  from T  cells which  might  be present  in  the  marrow.  Alternatively, re- 
population may be achieved from more primitive precursors. If these two types 
of cells have different physical properties, then it should be possible to distin- 
guish between these alternatives by using equilibrium density centrifugation as 
a means of separating cells in mouse bone marrow. 
Materials and Methods 
Mice.--Male C57BL/6J, DBA/2J, and C3H/HeJ mice, obtained from Jackson Laboratory, 
Bar Harbor, Maine, were used in the experiments when they were 7-9 wk old. 
Cell Suspensions.--Suspensions  of spleen  cells in phosphate-buffered  saline  (PBS)  were 
prepared as described  previously (6). Bone  marrow  cell suspensions  were prepared by re- 
moving both femora and flushing the cells out of the marrow cavity with PBS. The resulting 
clumps  of cells were passed through a  fine needle to produce a  single-cell suspension.  Cells 
designated for the density separation procedure were washed and suspended in the buffer to 
be used in the density gradient. For the mixed leukocyte reaction (MLR), the cells were 
suspended in tissue culture medium as previously described (6). For transplantation, the cells 
were suspended in PBS. 
Cell Separation.---C57BL/6J  marrow  cells were separated by density centrifugation on a 
linear gradient of Ficoll using the method described by Gorczynski et al. (7). By the addition 
of an appropriate amount of buffer, the Ficoll (Pharmacia, Uppsala, Sweden) was adjusted to 
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294 mosmol with respect to the water content. The buffer pH was 5.5. From 2 to 4  X  108 mar- 
row cells were uniformly distributed throughout both chambers of tow- and high-density Ficoll. 
Then a  linear gradient was generated by pumping low-density Ficoll into the chamber con- 
taining high-density Fico]l at half the rate of the outflow of the (lense Ficoll. The gradient was 
prepared in a 30 ml cellulose nitrate tube (Beckman Instruments, Inc., Fullerton, Calif.) in a 
period of 30 min. Then the cells were centrifuged at 3,800 g for 45 rain using an SW-25 rotor. 
After centrifugation, 2-ml fractions were collected by upward displacement of the gradient 
using dense Ficoll as the displacing agent. Each fraction was mixed, and the refractive index 
read in a  refractometer  (Abby  Refractometer, Bausch and  Lomb,  Inc.,  Rochester, N.  Y.). 
The cells were washed once in PBS. A sample was removed, and after addition of Zap-Isoton 
(Coulter  Diagnostics,  Inc.,  Hialeah,  Fla.)  the  number  of nucleated  cells per  fraction  was 
counted with an electronic cell counter (Coulter Counter Model F, Coulter Electronics, Inc., 
Hialeah, Fla.). With the aid of a computer program the nucleated cell counts and the density 
per fraction were calculated. For culture, the cells in each fraction were adjusted to the desired 
concentration in an appropriate volume of tissue culture medium. The cells were kept at 4°C 
throughout these procedures. 
Mixed  Leukocyte  Cultures.--The  procedure  was as  described  for  mouse  spleen cells  (6). 
Briefly, the culture medium consisted of alpha medium minus nucleosides (Flow Laboratories, 
Inc., Rockville, Md.)  supplemented with  10%  fetal calf serum  (FCS)  (Flow Laboratories). 
Test cultures consisted of mixtures of "responding" marrow cells and allogeneic "stimulating" 
spleen cells.  Control  cultures  consisted of responding cells equal  to  those used in  the  test 
cultures mixed with an  appropriate  number of heavily irradiated  isogeneic spleen cells.  In 
addition, a  mixture of heavily irradiated responding cells and heavily irradiated  stimulating 
cells was also incubated as a check on the effectiveness of the dose of irradiation in abolishing 
the response. 
Test and control cultures were set up in  triplicate for each experimental group.  After a 
16 h pulse with [ 3H]thymidine, the cells were harvested at 136 h, since preliminary experiments 
showed the peak response to occur at this time. 
Spleen  Colony Assay.--We  used the procedure described by Till  and  McCulloch  (8).  In 
summary,  5  X  104 bone marrow cells were injected intravenously into irradiated  (800 rad) 
recipients; 9  days later the spleens were removed, fixed in  Bouin's solution, and  scored for 
macroscopic colonies. 
Irradiation  Procedure.  A  137Cs unit  (9)  was used to irradiate cells and mice. Stimulating 
cells in  the MLR  received 2,500  rad.  In experiments involving transplantation  of marrow, 
isogeneic recipients received 800 rod, while allogeneic recipients used for graft-vs.-host disease 
(GVHD)  experiments received 1,200 rad 1-2 h  before transplantation. 
'~lCr Release Assay.--We used the method described by MacDonald (10). Briefly, C57BL/ 
6J bone marrow cells were mixed with irradiated (1,2G0 tad)  DBA/2J  spleen cells in plastic 
tubes (Falcon Plastics, Inc., Oxnard, Calif.) in a  total volume of 3 ml of a  medium plus 10% 
FCS. Triplicate cultures were used. After incubation for 6 days at 37°C in a humidified atmos- 
phere of 5% CO2 in air, sensitized cultures were resuspended with a  Pasteur pipette. Serial 
dilutions of pooled cultures were incubated with  1  >(  105  51Cr-labeled DBA mastocytoma 
tumor cells in tissue culture medium for another 5  6 h. Then the assay cultures were diluted 
to a constant volume and spun at 1,000 rpm for 10 rain. A constant proportion of supernatant 
was removed and counted in a well-type scintillation counter. Cultures containing no cells or 
unsensitized cells served as controls. Specific cytotoxicity was calculated as follows: 
cpm (sensitized) -- cpm (control) 
Specific cytotoxicity =  X  100. 
cpm (total)  -- cpm (control) 
The  specific cytotoxicity was plotted against  the logarithm of the ratio  of effector ceils to 
target cells. Such a  plot gives a  series of parallel lines for cultures with different cytotoxic M.  O.  EL-ARINI  AND  D.  OSOBA  823 
activities  (10). The relative number of effector cells in different cultures can be estimated by 
comparing, for the various groups, the effector to target cell ratio giving the same degree of 
cytotoxicity. 
Anti-O Antibody.--Anti-Ù ascitlc fluid was a generous gift from R.  Gorczynski and was 
used as previously described  (11). In summary,  cells to be  treated  were suspended at  10  T 
cells/ml in standard  medium. Anti-0 ascitic fluid was added in a concentration  of 1:5 or 1:2 
and the mixture was incubated  for 60 min at 37°C. At this time, the cells were washed and 
resuspended in a 10% solution of guinea pig serum in standard medium for another 45 min 
at 37°C. After this incubation the cells were washed three times in standard  medium. Control 
experiments include treatment of cells with anti-0 alone, complement alone, or no treatment. 
RESULTS 
Response of Mouse Bone Marrow Cells in the MLR.--Initially, we tested the 
capacity of unfractionated  C57BL/6J  mouse bone  marrow  to respond  in  the 
MLR. In several experiments,  there was no response above background levels. 
Nevertheless,  we  reasoned  that  if  mouse  marrow  contains  MLR-responsive 
cells,  the presence of such cells may be obscured by other cells capable of in- 
corporating [aH]thymidine. However, if the density profile oI these cells is differ- 
ent  than  that  of MLR-responsive  cells,  the  latter  may become evident  after 
separation of mouse bone marrow by density centrifugation. Therefore, C57BL/ 
6J bone marrow cells were subjected  to density centrifugation  and from each 
fraction a sample of 106 cells was mixed with 4 X  106 heavily irradiated  DBA/2J 
spleen  cells. In some  experiments,  the  light-density  regions  yielded an insuffi- 
cient number of cells to enable an independent assay of each fraction.  To over- 
come this problem, adjacent fractions were pooled to obtain the required num- 
ber of cells for both the test and control cultures. Thus, the total number of cells 
per culture was constant for all  regions  of the  gradient. Control  cultures  con- 
sisted of  106 fractionated  C57BL/6J  cells  mixed with 4  X  106 heavily  irradi- 
ated isogeneic spleen  cells.  The results  of  a  typical  experiment  are  shown  in 
Fig.  1 and in Table I. The total  activity per fraction (Fig. 2) was obtained as 
follows: 
Number  of nucleated  cells/fraction 
Net response/10 ~ X  106 
The results show that after bone marrow cells are subjected to density cen- 
trifugation  a  profile  of cells  capable  of responding  in  the  MLR  becomes ap- 
parent.  The  results  of four  experiments  show  that  these  cells  have  a  modal 
density of 1.069 g/cm  a (SD -t- 0.001). 
Behavior  of Mouse Bone Marrow Cells in the 51Cr Release A ssay.--We studied 
the  capacity of fractionated  C57BL/6J bone marrow cells,  sensitized  in vitro 
against  DBA/2J  antigens,  to  lyse  51Cr-labeled  DBA/2J  mastocytoma  cells. 
After density  centrifugation,  adjacent  fractions containing cells  responsive  in 
the MLR  (in the density region  1.06-1.08  g/cm  3)  were combined to give one 
pool (pool B) and adjacent fractions containing cells in the light-density region 
(1.05-1.059 g/cm  a) were combined to give another pool of cells (pool A). Sam- 824  T  CELL  DIFFERENTIATION 
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FIG. 1.  The response by fractionated C57BL/6J bone marrow cells in the MLR;  O  O, 
test cultures; X  N, control cultures.  Each point represents the mean counts per minute 
in triplicate cultures; the bars represent 1 SE above and below the mean. 
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FIG. 2.  Density profiles of C57BL/6J  bone  marrow  cells capable of responding  in  the 
MLR (© .... O) and capable of forming colonies (CFU-S) in the spleen (X  X). 
ples of 6  X  l0  s cells from each pool and from unfractionated marrow were cul- 
tured with 8 X  106 heavily irradiated DBA/2J spleen cells for 6 days. As a con- 
trol, we cultured 6  X  106 C57BL/6J spleen cells and 8 X  108 irradiated DBA/2J 
spleen cells for a  similar period of time. To test for immunological specificity in 
the response,  we cultured  C57BL/6J  cells from each  of  these groups with ir- 
radiated spleen cells carrying different antigens  than  the  sensitizing antigens, M.  O.  EL-ARINI  AND  D.  OSOBA  825 
i.e., C3H/HeJ  spleen cells. After harvesting the cells in each group, they were 
tested for their capacity to lyse DBA/2J mastocytoma cells. 
The results (Table I)  show  that after incubation with DBA/2J  spleen cells 
for 6  days, unfractionated marrow contains very few effector cells (1% lysis). 
However,  fractionated cells from pool B  are enriched for  effector cells (14% 
TABLE I 
Responses by Fractionated Bone Marrow Cells in Various Assays 
51Cr 
Cells  Density region  M_LR*  CFU-S:~  release§ 
colonies/  % 
g/cm3  c~n =i= SE  spleen 4- SE 
Fractionated bone  1.05-1.059  Test  3,750  4- 485 
marrow  Control  4,890  4-  720  32  4- 0.7  0 
Net  N.S.I] 
Bone marrow 
Spleen 
1.06-1.08  Test  11,225  4-  1,980 
Control  5,600  -4- 690  7  4-  2.5  14 
Net  5,625  4-  2,100 
Unfractionated  Test  6,440  4-  2,590 
Control  5,190  4-  1,300  10  4- 0  1 
Net  250  4-  2,890 
Unfracfionated  Test  5,300  4-  1,730 
Control  270  4- 40  N.D.¶  57 
Net  5,030  4-  1,730 
* 106  C57BL/6J  bone marrow cells were  incubated with 4  X  106 irradiated DBA/2J 
spleen cells for 5 days. The mean counts per minute in control cultures (106 C57BL/6J bone 
marrow cells and 4 X  106 irradiated C57BL/6J spleen cells) was subtracted from the mean 
counts per minute in the test cultures to obtain the net counts per minute per culture. 
Each irradiated recipient in the spleen colony assay received 5 X  104 C57BL/6J  bone 
marrow cells. 
§ 6 X  106 C57BL/6J bone marrow cells were incubated with 8 X  106 irradiated DBA/2J 
spleen cells for 6 days. Then cells from these cultures were mixed with 105 51Cr-labeled DBA/ 
2J mastocytoma cells and incubated for a further 5 h. As a control, 6 X  106 C57BL/6J spleen 
cells were treated in a similar way. 
I[ Not significant. 
¶ Not done. 
lysis), whereas cells from pool A  did not produce any detectable lysis. Neither 
C57BL/6J  spleen nor bone marrow cells sensitized to C3H/HeJ  antigens pro- 
duced  lysis of DBA/2J  target  cells. Therefore,  fractions  of  C57BL/6J  bone 
marrow  containing cells capable of responding  to DBA/2J  cells in the MLR 
also contain cells capable of becoming effector cells. However, the frequency of 
these cells is less than  that present in suspensions of C57BL/6J  spleen cells as 
determined from  experiments done  in parallel with  the  bone  marrow  experi- 
ments (Table I). 826  T  CELL  DIFFERENTL~.TION 
Dose-Response  Curve by  Bone  Marrow  Cells Capable of Responding  in  the 
MLR.--We  determined  the  dose-response  curve  by  fractionated  C57BL/6J 
bone marrow cells. Adjacent fractions containing cells capable of responding in 
the MLR were pooled; varying numbers of these  cells  (0.5-2  X  106) were cul- 
tured with  4  X  106 heavily irradiated DBA/2J spleen cells. Controls  consisted 
of a  similar number of responding cells cultured with isogeneic irradiated spleen 
cells. It is evident that within the range of cells cultured  a  linear dose-response 
relationship  exists  (Fig.  3).  Furthermore,  the  intercept  of  the  line  obtained 
'n~  6 
5 
I  1  t  i 
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No. of responding  cells(xlO  6) 
FIG. 3.  Dose-response curve  of fracfionated  C57BL/6J  marrow  cells from  the  density 
region 1.06-1.08 g/cm  3 capable of responding in the MLR. Varying numbers  (0.5-2 X  106) 
of fractlonated  cells were incubated with 4 X  l0 G  heavily irradiated  DBA/2J spleen cells for 
6 days. The error bars represent  1 SE above and below the mean. 
by the least-squares method did not differ significantly from zero  (within  95 % 
confidence limits). 
Eject of A nti-O Antibody on the MLR by Bone Marrow Cells.--MLR-respon- 
sive  cells  from fractionated  C57BL/6J  bone  marrow  cells  were  treated  with 
anti-0  ascitic fluid  and  guinea pig  serum  (a  source  of complement).  Controls 
consisted of fractionated untreated cells or cells treated with anti-0 ascitic fluid 
alone, or complement alone. We found that fractionated  C57BL/6J  bone mar- 
row  cells  treated  with  anti-0 ascitic  fluid  and  complement produced  a  much 
lower response in the MLR than did the cells in the control cultures (Table II). M.  O.  EL-ARINI  AND  D.  OSOBA  827 
Therefore, we conclude that mouse bone marrow contains T  cells capable of re- 
sponding in the MLR. 
Density Profile of ttematopoietic  Colony-Forming  Cells  (CFU-S).--Previous 
work has shown  that  CFU-S  capable of forming colonies in  the  spleens of re- 
cipient mice are present in a light-density region of density gradients (12, 13). In 
order to have a  base line for further experiments,  we also determined  the pro- 
file of CFU-S. C57BL/6J bone marrow cells were separated by density centrifu- 
gation,  and  samples of 5  X  104 cells from each fraction  were injected  into  ir- 
radiated  isogeneic recipients.  The total number of CFU-S per fraction was ob- 
tained as follows: 
Number  of  nucleated  cells/fraction 
Number of colonies/spleen  X 
5  X  104 
The profile of CFU-S was found to have a  modal density of 1.06 g/cm  3 (SD -4- 
TABLE  II 
Effect o/ Anti-~ Antibody on the MLR by C57BL/6J  Bone Marrow Celts* 
Treatment  Net cpm 4- 1 SE 
Anti-~ alone  2,755  4-  955 
Complement alone  3,140  4-  1,020 
Anti-~ plus complement  620  4-  565 
Nil  4,490  4-  245 
* Fractionated  C57BL/6J  bone  marrow cells from the  density region  1.06-1.08  g/cm  3 
were treated as indicated,  and 2 X  106 cells were incubated with 4 >( 106 irradiated DBA/2J 
spleen cells for 136 h. 
0.002)  (Fig. 2). This modal density is similar to that found for CFU-S in C57BL/ 
6J spleen cells. 2 Therefore, CFU-S in mouse bone marrow are found in a lighter 
density region  of the  gradient  than  are  the  cells capable of responding  in  the 
MLR. 
Production of G VttD by Fractionated Bone Marrow Cells.--To determine  the 
region of the gradient  containing  cells capable of producing  acute  GVHD,  we 
followed the experimental protocol outlined in Fig. 4. C57BL/6J  bone marrow 
cells were subjected  to density centrifugation.  Adjacent regions of the gradient 
enriched primarily for CFU-S (density region 1.05-1.059 g/cm  3) were combined 
to  give one pool of cells  (pool A).  The  remaining  fractions  enriched  for cells 
responsive  in  the  MLR  (density  region  1.06-1.08  g/cm  ~)  were  combined  to 
give a second pool of cells (pool B). Samples of 4 X  106 cells from each pool were 
transplanted  into  heavily  irradiated  C3H/HeJ  recipients.  A  third  group  (C) 
received  4  X  106  C57BL/6J  unseparated  bone  marrow  cells.  In  addition,  a 
2 EI-Arini,  M.  O., and D.  Osoba. Physical properties of mouse  spleen cells involved  in 
cell-mediated immunity. J. Immunol. In press. 828  T  CELL  DIFFERENTIATION 
fourth  control  group  of  C3H/HeJ  irradiated  recipients  was  given  4  X  106 
isogenic unseparated bone marrow  cells.  From previous studies  (14)  we  rea- 
soned  that pools A  and  B  contain  sufficient CFU-S  to prevent  death  from 
hematopoietic failure after irradiation. Therefore, isogeneic bone marrow cells 
were not given to C3H/HeJ recipients receiving cells from each of these pools. 
Mice receiving either unseparated  allogeneic bone marrow  cells  (group  C) 
or allogeneic cells  from pool B  of the gradient began  to die of acute GVHD 
12-14  days after transplantation (Fig. 5).  All of the mice receiving cells from 
pool  B  were dead by day 20,  while all of the mice receiving unfractionated 
allogeneic cells died by day 28. Mice receiving cells from pool A began to die 
from GVHD on day 21. However, 44 % of them were still alive on day 45. Thus, 
mice receiving allogeneic cells from a region of the gradient enriched for MLR- 
C57BLI6J 
Bone marrow 
Fractionate 
/\ 
Pool A  Pool B 
1.  NLR 
2. 51Cr  release assay 
3. Transplant  for GVHD ........_..~  group A 
assay  ~  group B 
Transplant for 
GVHD assay 
\ 
Group C 
FIc.  4.  Experimental  protocol for  testing  the  capacity  of fractionated  C57BL/6J  bone 
marrow cells to produce GVHD in irradiated allogeneic recipients. 
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FIG.  5.  The survival of irradiated  C3H/HeJ  mice receiving transplants of 4  X  106 frac- 
tionated C57BL/6J  bone marrow cells from pool A  (0----0),  pool B  (O  O),  unfrac- 
tionated C57BL/6[ bone marrow cells  (A----A),  and 4 X  106 isogeneic bone marrow ce]ls 
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responsive cells died of GVHD at an earlier time than did mice receiving cells 
from regions of the gradient depleted for MLR-responsive cells,  but enriched 
for CFU-S. 
Repopulation of the Lymphoid System by Fractionated Bone Marrow Cells.- 
In these experiments, we attempted to determine which region of the gradient 
contains cells capable of repopulating the immunological system, as assayed by 
the capacity to give rise to cells which would respond in the MLR and produce 
acute GVHD. The experimental protocol is shown in Fig. 6. Based upon the 
density distribution  of MLR-responsive cells and CFU-S  in previous experi- 
ments, we divided the gradient into three regions and combined adjacent frac- 
Day 0 
C57BL/6J 
Bone marrow 
I 
Fractionate 
/  I  "-.. 
Pool A  Pool B  Pool C 
1. MLR 
2.51Cr  release  assay 
3.  Spleen  colony assay  (CFU-S) 
Spleen cells 
Day 15 
1. MLR 
2. 51Cr  release  assay 
3. Transplant for GVHD 
assay 
4. Transplant into  .._..__.._..-----~  Group A 
irradiated  =Group B 
isogeneic recipients  ~6roup  C 
Fro. 6.  Experimental protocol for the study of the regeneration of immunocompetent cells 
in irradiated C57BL/6J  mice after transplantation of fractionated isogeneic  bone marrow 
cells. 
lions in  each  region  to give three  pools  of cells.  Cells  in  pool A  came from 
fractions having a density range of 1.05-1.059 g/cm  a. Therefore, this pool is en- 
riched for CFU-S and contains few, if any, MLR-responsive cells. Pool B con- 
tains cells from fractions having a density range of 1.06-1.07 g/cm  a. It contains 
a  mixture of MLR-responsive cells and CFU-S. Pool C  contains cells coming 
from fractions with a density range of 1.071  1.079 g/cm  a, and therefore contains 
some MLR-responsive cells but very few CFU-S. As a base line, samples of cells 
from each pool were assayed for the presence of CFU-S  and cells capable of 
responding in the MLR and the 51Cr release assays before transplantation (day 
0). Then samples of 4  X  106 cells from each pool were injected into different 
groups of irradiated isogeneic recipients.  15 days later,  the recipients' spleens 
were removed and tested for the presence of cells capable of responding in the 
MLR and 51Cr release assays as well as for cells with  the capacity to induce 
acute GVHD in allogeneic recipients (DBA/2J). 830  T  CELL  DI~'~'ERENTIATION 
The inoculum of cells from pool A  contains no MLR-responsive cells or cells 
capable of lysing specific target  cells; it contains the majority of CFU-S  (Fig. 
7).  The  inoculum  of cells from pool  B  contains  most of  the  MLR-responsive 
cells and some  CFU-S,  while  the inoculum from  pool  C  contains  few  MLR- 
responsive cells and very few CFU-S. However, assays of the spleens from each 
group of recipients  15 days after transplantation  for MLR-responsive cells and 
cells active in the  51Cr release  assay showed that  the greatest  activity in both 
of these  assays came from mice which had  been  transplanted  with  cells from 
pool A  (Fig.  7,  Table  III).  Furthermore,  spleen  cells from recipients  of bone 
marrow  cells  in pool A  were  also  active  in  producing  acute  GVHD  (Fig.  8). 
FIG. 7.  The results of a typical experiment using the protocol outlined in Fig. 6. The number 
of CFU-S and the MLR activity (net counts per minute) in the inoculum of 4 ;<  10 6 trans- 
planted  C57BL/6J bone marrow cells from each pool before transplantation  (day 0)  is repre- 
sented by the dotted and open columns, respectively. The MLR activity recovered per  spleen 
in irradiated  C57BL/6J recipients 15 days after transplantation  is represented by the shaded 
column. Spleen cells from irradiated  C57BL/6J  mice not given a transplant  of bone marrow 
assayed 15 days after irradiation did not produce a detectable  MLR response. 
Spleen  cells  obtained  from recipients  of bone marrow  cells  from pool  B  were 
also  active  in  all  three  assays,  but  the  spleen  cells  from  recipients  of  bone 
marrow  from pool  C  showed  little  activity.  Therefore,  these  results  indicate 
that  region A, although not containing any detectable  cells responding in the 
MLR or giving rise  to effector cells  before transplantation,  nevertheless  con- 
tains  a  class  of ceils  which  develop  into  immunocompetent  cells  after  trans- 
plantation into isogeneic recipients. 
Nature  of the Immunocompetent Cells Present in the Spleens of Mice Trans- 
planted with  Fractionated Bone Marrow.--Since  the  cells  obtained  from  the 
spleens  of  recipients  of  mice  transplanted  with  bone  marrow  cells  from  the 
light-density region of the gradient are capable of responding in the MLR and 
giving rise  to  GVHD,  it  is  likely  that  they  are  T  cells.  Therefore,  we  deter- M.  O.  EL-ARINI AND  D.  OSOBA  831 
mined the effect of anti-0 antibody on the spleen cells of these recipients. The 
results show that treatment with anti-0 ascitic fluid and complement markedly 
reduces the capacity of these cells to respond in the MLR (Table IV). There- 
TABLE III 
Capacity  of Spleen  Cells from  Recipients  of C57BL/6J  Fractionated Marrow  Cells to  Lyse 
51Cr-Labeled Target Cells* 
Cells assayed  ~lCr release 
% 
Spleen cells of irradiated  mice receiving fracfionated  bone  marrow 
from the density region: 
1.05-1.059 g/cm  3  28 
1.06-1. 070 g/cm  3  18 
1.071-1.079  g/cm  ~  16 
Normal spleen cells:~ (control)  68 
* 6 X  106 spleen cells from each group of recipients were incubated with 6 X  106 irradi- 
ated  DBA/2J spleen cells for 4 days. Then cells from these cultures were mixed with  105 
51Cr-labeled DBA/2J mastocytoma cells and incubated for a further 5 h. 
:~ Control  consists of 6  X  106 normal C57BL/6J  spleen cells incubated  with  6  X  106 
DBA/2J irradiated  spleen cells as above. 
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FIG. 8.  Survival of irradiated  DBA/2J  mice receiving only  106 isogeneic marrow cells 
(A  A), or  106 isogeneic marrow cells plus  l0  T spleen cells from irradiated  C57BL/6J 
recipients of fractionated C57BL/6J bone marrow from pool A (O  O), pool B (O  O), 
and pool C (A  A). 
fore, we conclude that the immunocompetent cells in these spleens are  indeed 
T  cells. 
Effect  of Treatment with A nti-O Antibody  on the Progenitors  of T  Cells.--The 
capacity of cell suspensions from the light-density region of  fractionated bone 
marrow  cells  to  give  rise  to  immunocompetent cells  in irradiated  recipients 832  T  CELL  DIFFERENTIATION 
can be interpreted in two ways. Either this suspension of cells is contaminated 
by T  cells capable of giving rise to more T  cells in the recipients, or it contains 
progenitors of T  cells. To exclude the possibility of contamination by T  cells, a 
suspension of cells obtained from the light-density region of the gradient (den- 
sity range 1.05-1.059 g/cm  3)  was treated with anti-0 ascitic fluid and  comple- 
ment  before  transplantation into  isogeneic  irradiated  recipients.  A  control 
group consisted of mice receiving cells from the same density region not treated 
before  transplantation. 15  days later,  the  spleen cells from each  group of re- 
cipients were tested for the presence of MLR-responsive cells as described pre- 
viously. We found that treatment of the transplanted marrow cells with anti-0 
in the presence of complement had no effect on the subsequent development of 
cells capable of responding in the MLR  (Table V).  This result makes it un- 
likely that cell suspensions from the light-density regions were contaminated by 
TABLE IV 
Effect  of Anti-O  Antibody  on the Capacity  of Spleen  Cells Obtained from Recipients  of Bone 
Marrow Cells (Light-Density  Region Only)  to Respond in the MLR* 
Treatment 
Netcpm±lSE 
Exp. 1  Exp. 2 
Nil  1,420  4-  195  2,265  4-  145 
Anti-0$ alone  815  4-  210  2,680  4-  695 
Complement alone  1,245  4- 400  3,130  4-  1,485 
Anti-0 plus complement  58  4-  110  410  4-  195 
* See text for experimental protocol. 4 X  106 C57BL/6J  recipient spleen cells treated  as 
indicated, and then incubated with 4 M l0  G  heavily irradiated  DBA/2J spleen cells. 
$ A 1 in 2 dilution of anti-0 ascitic fluid. 
TABLE  V 
Elect of Anti-O Antibody on the Capacity  of Bone Marrow Cells from the Light-Density  Reflon 
to Give Rise to MLR-Responsive Cells and to Spleen  Colonies in Irradiated 
f sogeneic Recipients* 
Experiment  Treatment:~  Net cpm/4 X  l0  s  Colonies/spleen 
no.  spleen cells (=t=1 SE) 
1  Nil  5,565  4-  2,345  19  4-  1.8 
Anti-0 (1:5)§ plus complement  4,395  4-  2,280  16  -1-  2.6 
2  Nil  4,850  4-  520  14  ±  2 
Anti-0 (1:2)plus complement  3,320  4-  395  14  4-  1 
* See text for experimental protocol. The MLR assay was done using recipients'  spleen 
cells obtained 15 days after transplantation of fractionated  marrow from the density region 
1.05-1.059 g/cm  3 (pool A). 
:~ As a  positive control,  normal spleen cells were treated  with  anti-0 plus complement 
under the same conditions. The response in the MLR by these cells was 4% of the response 
in the untreated controls. 
§ Dilution of anti-0 ascitic fluid. Guinea pig serum was used as a source of complement. M.  O.  EL-ARINI  AND  D.  OSOBA  833 
T  cells capable of giving  rise  to more T  cells in  the  recipients.  Therefore,  we 
suggest  that  the  light-density  region  of the  gradient  contains  a  class  of cells, 
not sensitive to anti-~ antibody, that are progenitors of T  cells. We will refer to 
these progenitors as PT cells. 
Density  Profile for PT Cells.--To determine  the density profile for PT cells, 
C57BL/6J  bone marrow was subjected  to density centrifugation.  A  sample of 
4 X  106 cells from each fraction was injected into a group of irradiated (800 rad) 
isogeneic recipients.  Fractions in the light-density region yielded an insufficient 
number of cells to assay each fraction independently.  Therefore, these fractions 
were  pooled  to  give  two  large  fractions;  the  first  one  included  cells  in  the 
density region  1.045-1.05  g/cm  3, the second included cells in  the  region  1.051- 
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Fro. 9.  Density profile for PT cells (O  O). The experimental  protocol used to obtain 
this profile is described in the text. For comparison,  the density profiles for cells responding 
in the MLR (----) and for CFU-S (- ..... ) from Fig. 2 are also shown. 
1.055  g/cm  3.  15  days  after  transplantation,  spleen  cells  from  each  group  of 
recipients  were  tested  for activity  in  the  MLR.  The  results  are  expressed  as 
counts per minute per spleen  (Fig.  9).  For comparison the density profiles for 
CFU-S and MLR in C57BL/6J bone marrow are shown in the same figure. 
The results show that the density profile for PT cells is different from those of 
T  cells  and  CFU-S.  PT  cells  (modal  density  of  1.064  g/cm  3)  are  lighter  in 
density than most T  cells but heavier than most CFU-S. This peak of PT cell 
activity was reproduced  in three experiments whereas  the other  two apparent 
peaks of PT cell activity present in the light and dense regions of the gradient as 
shown in Fig. 9 were not seen in the other two experiments. 
DISCUSSION 
Transplantation  of either mouse bone marrow or spleen cells into allogeneic 
recipients results in  GVHD  (15,  16).  In the case of spleen cells, it is generally 834  T  CELL  DIFFERENTL-kTION 
accepted that  the disease is produced by T  cells transferred in  the inoculum 
(17,  18). However, in the case of bone marrow transplants, the cellular basis for 
development of  GVHD  in  the recipients is  uncertain.  One possibility is  that 
normal mouse bone marrow contains sufficient numbers of T  cells capable of 
producing GVHD. Another possibility is that T cells capable of reacting against 
allogeneic tissue antigens are developed in the recipient from progenitors pres- 
ent in the bone marrow transplant.  In our experiments, we attempted to dis- 
tinguish between these two alternatives by using buoyant density centrifuga- 
tion  as  the means of obtaining  enriched populations of cells.  We found that 
normal mouse marrow contains a readily detectable population of cells capable 
of responding in  the MLR and of producing acute  GVHD  in irradiated allo- 
geneic recipients. These cells band at a modal density of 1.069 g/cm  3. Since the 
capacity of these cells to respond in the MLR is inhibited by the cytotoxic ac- 
tion of anti-0 antibody and complement, we conclude that they are T  cells. 
Having determined the position on density gradients of T  cells  present in 
mouse bone marrow cell suspensions, we then proceeded to test cells obtained 
from various regions of the gradient for their capacity to give rise to T  cells in 
irradiated recipients. We found that cells obtained from a light-density region 
of the gradient (1.050--1.059  g/cm  3) gave rise to immunocompetent cells in the 
spleens of irradiated isogeneic recipients within 15 days of transplantation. The 
cells in  the spleens of the recipients were capable of responding in  the MLR 
and  of producing acute  GVHD  when  transplanted  into  allogeneic irradiated 
recipients. Furthermore, the capacity of these cells to respond in the MLR was 
inhibited by pretreatment with anti-0  antibody and complement. To exclude 
the possibility that  the bone marrow cell suspension obtained from the light- 
density region of the gradient contained sufficient T  cells capable of repopulat- 
ing  the  immunological  system  of  the  irradiated  recipients,  we  repeated  the 
above experiment after pretreatment of the cell  suspension with  anti-0  anti- 
body and  complement. A  control group of irradiated  isogeneic recipients re- 
ceived cells from a  similar suspension not pretreated with anti-0 antibody and 
complement.  Spleen  cells  from these  two  groups  of  recipients had  an  equal 
capacity to respond in the MLR. Therefore, we can conclude that the T  cells 
found 15 days after transplantation in the recipients' spleens must have been 
derived from progenitor cells that are not sensitive to the cytotoxic action of 
anti-0 antibody. Therefore, these progenitor cells are not identical with T  cells. 
The identity of PT cells is still unclear. Since we do not have a dose-response 
relationship for PT cells,  precise determination of their activity profile is not 
possible.  However, the preliminary results indicate  that  the  PT cell activity 
profile shown  in  Fig.  9  appears  to  be different from  that  of T  cells  and  of 
CFU-S. PT cells are found mainly in the medium-density region of the gradient 
(modal density of 1.064 g/cm3). Thus, they are lighter in density than T  cells 
and heavier than CFU-S. Whereas T cells can react to foreign histocompatibility 
antigens,  PT cells do not,  but can give rise  to  cells with the properties of T 1Vf. O.  EL-ARINI AND  D.  OSOBA  835 
cells.  Furthermore,  treatment  with  anti-0  antibody and  complement inhibits 
T-cell function while having no effect on PT cells.  The relationship between 
PT cells and CFU-S is not clear at the present time. PT cells may represent  a 
subpopulation of CFU-S, or alternatively they may be related to each other in 
a parent-progeny relationship. 
Lafleur et al.  (19)  have identified a progenitor for bone marrow (B)  cells in 
mouse bone marrow (PB cell) and defined it as a cell that does not interact with 
sheep  erythrocytes and T  cells  to produce  a  significant  antibody response 8 
days later. However, this class of cells can differentiate to a cell population with 
properties similar to that of bone marrow cells.  In our experiments, the density 
measurements for PT cells appear to be similar to those obtained by Lafleur 
et al. for PB cells,  both having a peak modal density of  1.064 g/cm  3. This cor- 
relation may be interpreted as meaning that these two progenitors are identical. 
We believe that our results have a bearing on the use of density centrifugation 
as  a  means  of removing  immunocompetent  cells  from human  bone  marrow 
before transplantation  (20).  Even if it were possible to discard T  cells which 
might  be present  in  human  marrow,  the  light-density  region  to  be used  for 
transplantation  may contain  progenitors  capable of producing  GVHD  after 
differentiation in the host. On the other hand, these same progenitors may give 
rise to a T  cell population in the recipient necessary for normal immunological 
defenses.  Up to the present time,  the results of bone marrow transplantation 
indicate  that  the  most  successful  grafts  have  been  in  HL-A-identical  and 
MLR-negative siblings  (21).  The  results  of marrow  transplantation  in  other 
donor-recipient combinations have not been as successful. We suggest that the 
reason for these failures may  be explained by the presence,  in  the grafts, of 
progenitor  cells  capable  of  differentiating  into  cells  with  graft-vs.-host po- 
tential. 
SUMMARY 
An experimental model system was developed to study the differentiation of 
thymus-derived  (T)  cells  from progenitors  in  bone  marrow.  In  this  system 
transplantation of bone marrow cells depleted of T  cells gave rise to T  cells in 
the  spleens of irradiated  recipients within  15  days of transplantation.  Thus, 
normal bone marrow contains  a  class of cells  that  are progeniotrs of T  cells 
(PT cells). PT cells are different from T  cells since PT cells are incapable of 
responding to alloantigen, are 0 resistant,  and band in a lighter density region 
than do T  cells. The density profile of PT cells is different from that of hemato- 
poietic stem cells  (CFU-S);  PT cells band in  a  denser region of the gradient 
than do CFU-S. 
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